BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.035
+0.005 (0.25%)
Sep 4, 2026, 11:17 AM EDT - Market open
BioVie Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 8.98 | 17.54 | 23.84 | 19.46 | 18.64 |
Short-Term Investments | - | - | - | 14.48 | - |
Cash & Short-Term Investments | 8.98 | 17.54 | 23.84 | 33.94 | 18.64 |
Cash Growth | -48.83% | -26.42% | -29.74% | 82.06% | 313.19% |
Receivables | 2.15 | 2.1 | - | - | - |
Prepaid Expenses | 2.51 | 1.05 | 0.2 | 0.1 | 0.14 |
Total Current Assets | 13.64 | 20.7 | 24.05 | 34.04 | 18.78 |
Property, Plant & Equipment | 0.26 | 0.34 | 0.41 | 0.08 | 0.12 |
Goodwill | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
Other Intangible Assets | - | 0.18 | 0.41 | 0.64 | 0.87 |
Other Long-Term Assets | - | - | - | - | 0 |
Total Assets | 14.25 | 21.56 | 25.21 | 35.1 | 20.11 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 3.7 | 2.2 | 3.59 | 3.48 | 2.44 |
Accrued Expenses | - | - | - | 0.05 | 0.58 |
Current Portion of Long-Term Debt | - | - | 5.7 | 9.11 | - |
Current Portion of Leases | 0.09 | 0.07 | 0.06 | 0.04 | 0.04 |
Other Current Liabilities | - | - | 0 | 1.82 | 1.11 |
Total Current Liabilities | 3.8 | 2.27 | 9.35 | 14.49 | 4.17 |
Long-Term Debt | - | - | - | 5.23 | 12.14 |
Long-Term Leases | 0.18 | 0.28 | 0.35 | 0.04 | 0.09 |
Other Long-Term Liabilities | - | - | - | - | 0.05 |
Total Liabilities | 3.98 | 2.55 | 9.7 | 19.76 | 16.44 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0 | 0 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 384.53 | 371.16 | 349.73 | 316.39 | 254.64 |
Retained Earnings | -374.26 | -352.14 | -334.23 | -301.23 | -250.97 |
Treasury Stock | -0 | -0 | -0 | -0 | - |
Comprehensive Income & Other | - | - | - | 0.18 | - |
Shareholders' Equity | 10.27 | 19.01 | 15.51 | 15.34 | 3.67 |
Total Liabilities & Equity | 14.25 | 21.56 | 25.21 | 35.1 | 20.11 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.28 | 0.35 | 6.11 | 14.42 | 12.26 |
Net Cash (Debt) | 8.7 | 17.19 | 17.73 | 19.52 | 6.38 |
Net Cash Growth | -49.39% | -3.03% | -9.15% | 206.09% | 41.34% |
Net Cash Per Share | 1.20 | 11.64 | 39.24 | 60.09 | 25.86 |
Filing Date Shares Outstanding | 7.54 | 7.53 | 0.79 | 0.37 | 0.3 |
Total Common Shares Outstanding | 7.54 | 1.91 | 0.62 | 0.36 | 0.25 |
Working Capital | 9.85 | 18.42 | 14.7 | 19.55 | 14.61 |
Book Value Per Share | 1.36 | 9.93 | 25.05 | 42.11 | 14.69 |
Tangible Book Value | 9.92 | 18.49 | 14.75 | 14.36 | 2.46 |
Tangible Book Value Per Share | 1.32 | 9.66 | 23.83 | 39.41 | 9.84 |